BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riethdorf S, O'flaherty L, Hille C, Pantel K. Clinical applications of the CellSearch platform in cancer patients. Advanced Drug Delivery Reviews 2018;125:102-21. [DOI: 10.1016/j.addr.2018.01.011] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 30.3] [Reference Citation Analysis]
Number Citing Articles
1 Rossi T, Gallerani G, Angeli D, Cocchi C, Bandini E, Fici P, Gaudio M, Martinelli G, Rocca A, Maltoni R, Fabbri F. Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer. Cancers (Basel) 2020;12:E2490. [PMID: 32887501 DOI: 10.3390/cancers12092490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
2 Pantel K, Hille C, Scher HI. Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility. Clinical Chemistry 2019;65:87-99. [DOI: 10.1373/clinchem.2018.287102] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 27.0] [Reference Citation Analysis]
3 Abdalla TSA, Meiners J, Riethdorf S, König A, Melling N, Gorges T, Karstens KF, Izbicki JR, Pantel K, Reeh M. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer. PLoS One 2021;16:e0252897. [PMID: 34111181 DOI: 10.1371/journal.pone.0252897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rabiee N, Ahmadi S, Arab Z, Bagherzadeh M, Safarkhani M, Nasseri B, Rabiee M, Tahriri M, Webster TJ, Tayebi L. Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review. Int J Nanomedicine 2020;15:4237-56. [PMID: 32606675 DOI: 10.2147/IJN.S248736] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 10.0] [Reference Citation Analysis]
5 Reduzzi C, Vismara M, Gerratana L, Silvestri M, De Braud F, Raspagliesi F, Verzoni E, Di Cosimo S, Locati LD, Cristofanilli M, Daidone MG, Cappelletti V. The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells. Semin Cancer Biol 2020;60:344-50. [PMID: 31626958 DOI: 10.1016/j.semcancer.2019.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chen Y, Zhai LY, Zhang LM, Ma XS, Liu Z, Li MM, Chen JX, Duan WJ. Breast cancer plasma biopsy by in situ determination of exosomal microRNA-1246 with a molecular beacon. Analyst 2021;146:2264-76. [PMID: 33599630 DOI: 10.1039/d0an02224a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rafiee SD, Kocabey S, Mayer M, List J, Rüegg C. Detection of HER2+ Breast Cancer Cells using Bioinspired DNA-Based Signal Amplification. ChemMedChem 2020;15:661-6. [PMID: 31943804 DOI: 10.1002/cmdc.201900697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tzanikou E, Lianidou E. The potential of ctDNA analysis in breast cancer. Crit Rev Clin Lab Sci 2020;57:54-72. [PMID: 31674269 DOI: 10.1080/10408363.2019.1670615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Pantel K. Circulating Tumor Cells in Head and Neck Carcinomas. Clinical Chemistry 2019;65:1193-5. [DOI: 10.1373/clinchem.2019.309609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Keller L, Pantel K. Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells. Nat Rev Cancer. 2019;19:553-567. [PMID: 31455893 DOI: 10.1038/s41568-019-0180-2] [Cited by in Crossref: 115] [Cited by in F6Publishing: 119] [Article Influence: 57.5] [Reference Citation Analysis]
11 Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, Mauermann O, Waldispühl-Geigl J, Coith C, Schön G, Peine S, Schuler G, Speicher MR, Moll I, Pantel K. Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma. Clin Chem 2019;65:462-72. [PMID: 30626636 DOI: 10.1373/clinchem.2018.297028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
12 Li G, Wang Y, Tan G, Liu Y, Xu Z, Feng H, Xing W, Xu Z. [Preliminary Study on Detection of Circulating Tumor Cells in Lung Cancer by EGFR/Vimentin/Folic Acid Magnetic Sphere]. Zhongguo Fei Ai Za Zhi 2020;23:351-9. [PMID: 32336066 DOI: 10.3779/j.issn.1009-3419.2020.103.05] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Li Y, Wu G, Yang W, Wang X, Duan L, Niu L, Zhang Y, Liu J, Hong L, Fan D. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis. BMC Cancer 2020;20:581. [PMID: 32571299 DOI: 10.1186/s12885-020-07059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sun S, Yang S, Hu X, Zheng C, Song H, Wang L, Shen Z, Wu ZS. Combination of Immunomagnetic Separation with Aptamer-Mediated Double Rolling Circle Amplification for Highly Sensitive Circulating Tumor Cell Detection. ACS Sens 2020;5:3870-8. [PMID: 33205648 DOI: 10.1021/acssensors.0c01082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Shen Y, Chu Q, Yin X, He Y, Bai P, Wang Y, Fang W, Timko MP, Fan L, Jiang W. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary. Brief Bioinform 2021;22:2106-18. [PMID: 32266390 DOI: 10.1093/bib/bbaa031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang Y, Zhao J, Yu H, Li P, Liang W, Liu Z, Lee GB, Liu L, Li WJ, Wang Z. Detection and isolation of free cancer cells from ascites and peritoneal lavages using optically induced electrokinetics (OEK). Sci Adv 2020;6:eaba9628. [PMID: 32821829 DOI: 10.1126/sciadv.aba9628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
17 Nicolazzo C, Busetto GM, Gradilone A, Sperduti I, Del Giudice F, Loreni F, Cortesi E, de Berardinis E, Gazzaniga P, Raimondi C. Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial. Oncologist 2019;24:612-6. [PMID: 30944184 DOI: 10.1634/theoncologist.2018-0784] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
18 Gribko A, Künzel J, Wünsch D, Lu Q, Nagel SM, Knauer SK, Stauber RH, Ding GB. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives. Int J Nanomedicine 2019;14:4187-209. [PMID: 31289440 DOI: 10.2147/IJN.S198319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
19 Liu L, Yang K, Gao H, Li X, Chen Y, Zhang L, Peng X, Zhang Y. Artificial Antibody with Site-Enhanced Multivalent Aptamers for Specific Capture of Circulating Tumor Cells. Anal Chem 2019;91:2591-4. [PMID: 30675782 DOI: 10.1021/acs.analchem.8b05259] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
20 Lianidou E, Pantel K. Liquid biopsies. Genes Chromosomes Cancer. 2019;58:219-232. [PMID: 30382599 DOI: 10.1002/gcc.22695] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 26.5] [Reference Citation Analysis]
21 Cantini G, Canu L, Armignacco R, Salvianti F, De Filpo G, Ercolino T, Nesi G, Maggi M, Mannelli M, Pinzani P, Luconi M. Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study. Cancers (Basel) 2020;12:E3176. [PMID: 33138000 DOI: 10.3390/cancers12113176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Gao T, Li L, Chen T, Shi L, Yang Y, Li G. DNA-Oriented Shaping of Cell Features for the Detection of Rare Disseminated Tumor Cells. Anal Chem 2019;91:1126-32. [DOI: 10.1021/acs.analchem.8b04783] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Tozuka K, Wongsirisin P, Nagai SE, Kobayashi Y, Kanno M, Kubo K, Takai K, Inoue K, Matsumoto H, Shimizu Y, Suganuma M. Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer. Sci Rep 2021;11:14238. [PMID: 34244560 DOI: 10.1038/s41598-021-93620-y] [Reference Citation Analysis]
24 Dejima H, Nakanishi H, Kuroda H, Yoshimura M, Sakakura N, Ueda N, Ohta Y, Tanaka R, Mori S, Yoshida T, Hida T, Sawabata N, Yatabe Y, Sakao Y. Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform. Lung Cancer 2018;125:128-35. [PMID: 30429010 DOI: 10.1016/j.lungcan.2018.09.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zhang H, Lin X, Huang Y, Wang M, Cen C, Tang S, Dique MR, Cai L, Luis MA, Smollar J, Wan Y, Cai F. Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer. Front Oncol 2021;11:652253. [PMID: 34150621 DOI: 10.3389/fonc.2021.652253] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Stiller C, Viktorsson K, Paz Gomero E, Hååg P, Arapi V, Kaminskyy VO, Kamali C, De Petris L, Ekman S, Lewensohn R, Karlström AE. Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR. Cancers (Basel) 2021;13:922. [PMID: 33671772 DOI: 10.3390/cancers13040922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
27 Müller Bark J, Kulasinghe A, Hartel G, Leo P, Warkiani ME, Jeffree RL, Chua B, Day BW, Punyadeera C. Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology - A Pilot Study. Front Oncol 2021;11:681130. [PMID: 34150645 DOI: 10.3389/fonc.2021.681130] [Reference Citation Analysis]
28 Lv S, Chu Y, Zhang P, Ma S, Zhao M, Wang Z, Gu Y, Sun X. Improved efficiency of urine cell image segmentation using droplet microfluidics technology. Cytometry A 2021;99:722-31. [PMID: 33342063 DOI: 10.1002/cyto.a.24296] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Flores BCT, Correia MP, Rodríguez JG, Henrique R, Jerónimo C. Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer. Cancers (Basel) 2021;13:4209. [PMID: 34439363 DOI: 10.3390/cancers13164209] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Liu J, Peng X, Liu Y, Hao R, Zhao R, Zhang L, Zhao F, Liu Q, Liu Y, Qi Y. The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients. Int J Gen Med 2021;14:4545-54. [PMID: 34429639 DOI: 10.2147/IJGM.S319801] [Reference Citation Analysis]
31 Nicolazzo C, Gradilone A, Loreni F, Raimondi C, Gazzaniga P. EpCAMlow Circulating Tumor Cells: Gold in the Waste. Dis Markers 2019;2019:1718920. [PMID: 31636732 DOI: 10.1155/2019/1718920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
32 Siemer S, Wünsch D, Khamis A, Lu Q, Scherberich A, Filippi M, Krafft MP, Hagemann J, Weiss C, Ding GB, Stauber RH, Gribko A. Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy. Nanomaterials (Basel) 2020;10:E383. [PMID: 32098406 DOI: 10.3390/nano10020383] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
33 Huang X, Hu X, Song S, Mao D, Lee J, Koh K, Zhu Z, Chen H. Triple-enhanced surface plasmon resonance spectroscopy based on cell membrane and folic acid functionalized gold nanoparticles for dual-selective circulating tumor cell sensing. Sensors and Actuators B: Chemical 2020;305:127543. [DOI: 10.1016/j.snb.2019.127543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
34 Amelio I, Bertolo R, Bove P, Buonomo OC, Candi E, Chiocchi M, Cipriani C, Di Daniele N, Ganini C, Juhl H, Mauriello A, Marani C, Marshall J, Montanaro M, Palmieri G, Piacentini M, Sica G, Tesauro M, Rovella V, Tisone G, Shi Y, Wang Y, Melino G. Liquid biopsies and cancer omics.Cell Death Discov. 2020;6:131. [PMID: 33298891 DOI: 10.1038/s41420-020-00373-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
35 Wang PX, Sun YF, Jin WX, Cheng JW, Peng HX, Xu Y, Zhou KQ, Chen LM, Huang K, Wu SY, Hu B, Zhang ZF, Guo W, Cao Y, Zhou J, Fan J, Yang XR. Circulating tumor cell detection and single-cell analysis using an integrated workflow based on ChimeraX® -i120 Platform: A prospective study. Mol Oncol 2021;15:2345-62. [PMID: 33301640 DOI: 10.1002/1878-0261.12876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Miao P, Tang Y. Gold Nanoparticles-Based Multipedal DNA Walker for Ratiometric Detection of Circulating Tumor Cell. Anal Chem 2019;91:15187-92. [PMID: 31674765 DOI: 10.1021/acs.analchem.9b04000] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
37 Rink M, Schwarzenbach H, Riethdorf S, Soave A. The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder. World J Urol 2019;37:1785-99. [DOI: 10.1007/s00345-018-2543-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
38 Hu X, Zang X, Lv Y. Detection of circulating tumor cells: Advances and critical concerns. Oncol Lett 2021;21:422. [PMID: 33850563 DOI: 10.3892/ol.2021.12683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Lozar T, Jesenko T, Kloboves Prevodnik V, Cemazar M, Hosta V, Jericevic A, Nolde N, Grasic Kuhar C. Preclinical and Clinical Evaluation of Magnetic-Activated Cell Separation Technology for CTC Isolation in Breast Cancer. Front Oncol 2020;10:554554. [PMID: 33042837 DOI: 10.3389/fonc.2020.554554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
40 Wu J, Hu S, Zhang L, Xin J, Sun C, Wang L, Ding K, Wang B. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis. Theranostics 2020;10:4544-56. [PMID: 32292514 DOI: 10.7150/thno.40532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 26.0] [Reference Citation Analysis]
41 Su YH, Kim AK, Jain S. Liquid biopsies for hepatocellular carcinoma. Transl Res 2018;201:84-97. [PMID: 30056068 DOI: 10.1016/j.trsl.2018.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
42 Cheng Y, Luo L, Zhang J, Zhou M, Tang Y, He G, Lu Y, Wang Z, Pan M. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma. J Gastrointest Surg 2019;23:2354-61. [PMID: 30805878 DOI: 10.1007/s11605-018-04067-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
43 Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G. Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer. Cancers (Basel) 2021;13:485. [PMID: 33513877 DOI: 10.3390/cancers13030485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T. The biology and clinical potential of circulating tumor cells. Radiol Oncol 2019;53:131-47. [PMID: 31104002 DOI: 10.2478/raon-2019-0024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
45 Yoneda K, Imanishi N, Ichiki Y, Tanaka F. A liquid biopsy in primary lung cancer. Surg Today 2019;49:1-14. [PMID: 29644440 DOI: 10.1007/s00595-018-1659-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Janning M, Kobus F, Babayan A, Wikman H, Velthaus JL, Bergmann S, Schatz S, Falk M, Berger LA, Böttcher LM, Päsler S, Gorges TM, O'Flaherty L, Hille C, Joosse SA, Simon R, Tiemann M, Bokemeyer C, Reck M, Riethdorf S, Pantel K, Loges S. Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers (Basel) 2019;11:E835. [PMID: 31212989 DOI: 10.3390/cancers11060835] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 24.5] [Reference Citation Analysis]
47 Mansouri S, Mokhtari-Hesari P, Naghavi-Al-Hosseini F, Majidzadeh-A K, Farahmand L. The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review. Curr Stem Cell Res Ther 2019;14:519-29. [PMID: 30843493 DOI: 10.2174/1574888X14666190306103759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
48 Zhou X, Li Y, Wu H, Huang W, Ju H, Ding S. A amperometric immunosensor for sensitive detection of circulating tumor cells using a tyramide signal amplification-based signal enhancement system. Biosens Bioelectron 2019;130:88-94. [PMID: 30731350 DOI: 10.1016/j.bios.2019.01.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
49 Heitzer E. Circulating Tumor DNA for Modern Cancer Management. Clin Chem 2019:clinchem. [PMID: 31672857 DOI: 10.1373/clinchem.2019.304774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ribeiro IP, Melo JB, Carreira IM. Cytogenetics and Cytogenomics Evaluation in Cancer. Int J Mol Sci 2019;20:E4711. [PMID: 31547595 DOI: 10.3390/ijms20194711] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Chu Q, Mu W, Lan C, Liu Y, Gao T, Guan L, Fang Y, Zhang Z, Liu Y, Liu Y, Zhang N. High-Specific Isolation and Instant Observation of Circulating Tumour Cell from HCC Patients via Glypican-3 Immunomagnetic Fluorescent Nanodevice. Int J Nanomedicine 2021;16:4161-73. [PMID: 34168446 DOI: 10.2147/IJN.S307691] [Reference Citation Analysis]
52 Jia M, Mao Y, Wu C, Wang S, Zhang H. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy. Anal Chim Acta 2019;1082:136-45. [PMID: 31472702 DOI: 10.1016/j.aca.2019.07.051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
53 De Rubis G, Rajeev Krishnan S, Bebawy M. Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis. Trends Pharmacol Sci. 2019;40:172-186. [PMID: 30736982 DOI: 10.1016/j.tips.2019.01.006] [Cited by in Crossref: 162] [Cited by in F6Publishing: 152] [Article Influence: 81.0] [Reference Citation Analysis]
54 Liu H, Koch C, Haller A, Joosse SA, Kumar R, Vellekoop MJ, Horst LJ, Keller L, Babayan A, Failla AV, Jensen J, Peine S, Keplinger F, Fuchs H, Pantel K, Hirtz M. Evaluation of Microfluidic Ceiling Designs for the Capture of Circulating Tumor Cells on a Microarray Platform. Adv Biosys 2019;4:1900162. [DOI: 10.1002/adbi.201900162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
55 Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20:71-88. [PMID: 30410101 DOI: 10.1038/s41576-018-0071-5] [Cited by in Crossref: 363] [Cited by in F6Publishing: 344] [Article Influence: 181.5] [Reference Citation Analysis]
56 Ganig N, Baenke F, Thepkaysone ML, Lin K, Rao VS, Wong FC, Polster H, Schneider M, Helm D, Pecqueux M, Seifert AM, Seifert L, Weitz J, Rahbari NN, Kahlert C. Proteomic Analyses of Fibroblast- and Serum-Derived Exosomes Identify QSOX1 as a Marker for Non-invasive Detection of Colorectal Cancer. Cancers (Basel) 2021;13:1351. [PMID: 33802764 DOI: 10.3390/cancers13061351] [Reference Citation Analysis]
57 Williams PS, Moore LR, Joshi P, Goodin M, Zborowski M, Fleischman A. Microfluidic chip for graduated magnetic separation of circulating tumor cells by their epithelial cell adhesion molecule expression and magnetic nanoparticle binding. J Chromatogr A 2021;1637:461823. [PMID: 33385746 DOI: 10.1016/j.chroma.2020.461823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
58 De Palma FDE, Luglio G, Tropeano FP, Pagano G, D'Armiento M, Kroemer G, Maiuri MC, De Palma GD. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. Int J Mol Sci 2020;21:E7040. [PMID: 32987896 DOI: 10.3390/ijms21197040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
59 Li Q, Cui S, Xu Y, Wang Y, Jin F, Si H, Li L, Tang B. Consecutive Sorting and Phenotypic Counting of CTCs by an Optofluidic Flow Cytometer. Anal Chem 2019;91:14133-40. [DOI: 10.1021/acs.analchem.9b04035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Woestemeier A, Harms-Effenberger K, Karstens KF, Konczalla L, Ghadban T, Uzunoglu FG, Izbicki JR, Bockhorn M, Pantel K, Reeh M. Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method. Cancers (Basel) 2020;12:E718. [PMID: 32197486 DOI: 10.3390/cancers12030718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
61 Miccio L, Cimmino F, Kurelac I, Villone MM, Bianco V, Memmolo P, Merola F, Mugnano M, Capasso M, Iolascon A, Maffettone PL, Ferraro P. Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips. View 2020;1:20200034. [DOI: 10.1002/viw.20200034] [Cited by in Crossref: 17] [Article Influence: 17.0] [Reference Citation Analysis]
62 Xie YL, Yang Z, Feng X, Yang Q, Ye LS, Li XB, Tang H, Zhang YC, Liu W, Tong Zhang, Fu BS, Yi SH, Yang Y, Chen GH. Association of phenotypic transformation of circulating tumor cells and early recurrence in patients with hepatocellular carcinoma following liver transplantation. Asian J Surg 2021:S1015-9584(21)00477-2. [PMID: 34426060 DOI: 10.1016/j.asjsur.2021.07.058] [Reference Citation Analysis]
63 Cortés-Hernández LE, Eslami-S Z, Alix-Panabières C. Liquid Biopsy to Detect Circulating Tumor Cells: Is It Ready for a Value Proposition in Laboratory Medicine? J Appl Lab Med 2020;5:1027-37. [PMID: 32845318 DOI: 10.1093/jalm/jfaa115] [Reference Citation Analysis]
64 Hille C, Gorges TM, Riethdorf S, Mazel M, Steuber T, Amsberg GV, König F, Peine S, Alix-Panabières C, Pantel K. Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer. Cells 2019;8:E1067. [PMID: 31514447 DOI: 10.3390/cells8091067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
65 Tzanikou E, Markou A, Politaki E, Koutsopoulos A, Psyrri A, Mavroudis D, Georgoulias V, Lianidou E. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study. Mol Oncol 2019;13:2515-30. [PMID: 31254443 DOI: 10.1002/1878-0261.12540] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
66 Fehm TN, Meier‐stiegen F, Driemel C, Jäger B, Reinhardt F, Naskou J, Franken A, Neubauer H, Neves RP, Dalum G, Ruckhäberle E, Niederacher D, Rox JM, Fischer JC, Stoecklein NH. Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting. Cytometry 2018;93:1213-9. [DOI: 10.1002/cyto.a.23669] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
67 Wu C, Zhang J, Li H, Xu W, Zhang X. The potential of liquid biopsies in gastrointestinal cancer. Clin Biochem. 2020;84:1-12. [PMID: 32540214 DOI: 10.1016/j.clinbiochem.2020.06.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
68 Saini M, Aceto N. To Be Taken in Count: Prostatic Tumor Cells Break Free upon Needle Biopsy. Clinical Chemistry 2020;66:6-8. [DOI: 10.1373/clinchem.2019.311696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Tsutsuyama M, Nakanishi H, Yoshimura M, Oshiro T, Kinoshita T, Komori K, Shimizu Y, Ichinosawa Y, Kinuta S, Wajima K, Sakakibara Y, Yatabe Y, Ito S, Kodera Y. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform. PLoS One 2019;14:e0212221. [PMID: 30811434 DOI: 10.1371/journal.pone.0212221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
70 Labib M, Kelley SO. Circulating tumor cell profiling for precision oncology. Mol Oncol 2021;15:1622-46. [PMID: 33448107 DOI: 10.1002/1878-0261.12901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
71 Müller Bark J, Kulasinghe A, Chua B, Day BW, Punyadeera C. Circulating biomarkers in patients with glioblastoma. Br J Cancer 2020;122:295-305. [PMID: 31666668 DOI: 10.1038/s41416-019-0603-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 22.5] [Reference Citation Analysis]
72 Hong S, Wang AZ. Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers. Adv Drug Deliv Rev 2018;125:1-2. [PMID: 29880212 DOI: 10.1016/j.addr.2018.04.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
73 Meirson T, Gil-Henn H. Targeting invadopodia for blocking breast cancer metastasis. Drug Resist Updat 2018;39:1-17. [PMID: 30075834 DOI: 10.1016/j.drup.2018.05.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
74 Geeurickx E, Hendrix A. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics. Mol Aspects Med. 2020;72:100828. [PMID: 31711714 DOI: 10.1016/j.mam.2019.10.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
75 Koch C, Joosse SA, Schneegans S, Wilken OJW, Janning M, Loreth D, Müller V, Prieske K, Banys-Paluchowski M, Horst LJ, Loges S, Peine S, Wikman H, Gorges TM, Pantel K. Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients. Cancers (Basel) 2020;12:E442. [PMID: 32069934 DOI: 10.3390/cancers12020442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
76 Buscail E, Chiche L, Laurent C, Vendrely V, Denost Q, Denis J, Thumerel M, Lacorte JM, Bedel A, Moreau-Gaudry F, Dabernat S, Alix-Panabières C. Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells. Mol Oncol 2019;13:1811-26. [PMID: 31216108 DOI: 10.1002/1878-0261.12534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
77 Dong J, Chen JF, Smalley M, Zhao M, Ke Z, Zhu Y, Tseng HR. Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Adv Mater 2020;32:e1903663. [PMID: 31566837 DOI: 10.1002/adma.201903663] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
78 Dong J, Jan YJ, Cheng J, Zhang RY, Meng M, Smalley M, Chen PJ, Tang X, Tseng P, Bao L, Huang TY, Zhou D, Liu Y, Chai X, Zhang H, Zhou A, Agopian VG, Posadas EM, Shyue JJ, Jonas SJ, Weiss PS, Li M, Zheng G, Yu HH, Zhao M, Tseng HR, Zhu Y. Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells. Sci Adv 2019;5:eaav9186. [PMID: 31392269 DOI: 10.1126/sciadv.aav9186] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
79 Chen Y, Chen X, Li M, Fan P, Wang B, Zhao S, Yu W, Zhang S, Tang Y, Gao T. A new analytical platform for potential point-of-care testing of circulating tumor cells. Biosens Bioelectron 2021;171:112718. [PMID: 33059165 DOI: 10.1016/j.bios.2020.112718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
80 Joosse SA, Beyer B, Gasch C, Nastały P, Kuske A, Isbarn H, Horst LJ, Hille C, Gorges TM, Cayrefourcq L, Alix-panabières C, Tennstedt P, Riethdorf S, Schlomm T, Pantel K. Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer. Clinical Chemistry 2020;66:161-8. [DOI: 10.1373/clinchem.2019.310912] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
81 Neves RPL, Ammerlaan W, Andree KC, Bender S, Cayrefourcq L, Driemel C, Koch C, Luetke-Eversloh MV, Oulhen M, Rossi E, Alix-Panabières C, Betsou F, Farace F, Riethdorf S, Schlange T, Wikman H, Zamarchi R, Pantel K, Terstappen LWMM, Stoecklein NH; CANCER-ID Consortium. Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID. Clin Chem 2021;67:631-41. [PMID: 33491069 DOI: 10.1093/clinchem/hvaa322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
82 Sistigu A, Musella M, Galassi C, Vitale I, De Maria R. Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening. Front Immunol 2020;11:2166. [PMID: 33193295 DOI: 10.3389/fimmu.2020.02166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
83 Singh B, Arora S, D'Souza A, Kale N, Aland G, Bharde A, Quadir M, Calderón M, Chaturvedi P, Khandare J. Chemo-specific designs for the enumeration of circulating tumor cells: advances in liquid biopsy. J Mater Chem B 2021;9:2946-78. [PMID: 33480960 DOI: 10.1039/d0tb02574g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Alix-Panabieres C, Magliocco A, Cortes-Hernandez LE, Eslami-S Z, Franklin D, Messina JL. Detection of cancer metastasis: past, present and future. Clin Exp Metastasis 2021. [PMID: 33961169 DOI: 10.1007/s10585-021-10088-w] [Reference Citation Analysis]